Yuan Liming, Cao Yiting, Luo Qian, Yang Wenyu, Wu Xiaofeng, Yang Xiaoping, Wu Di, Tan Siyuan, Qin Ge, Zhou Jia, Zeng Yue, Chen Xinghua, Tao Xiaojun, Zhang Qiufang
Key Laboratory of Study and Discovery of Small Targeted Molecules of Hunan Province, School of Medicine, Hunan Normal University, Changsha, 410013, China.
Department of Pharmacology, Hubei University of Medicine, Shiyan, 442000, Hubei, China.
Nanoscale Res Lett. 2018 Oct 10;13(1):317. doi: 10.1186/s11671-018-2729-5.
The nanomaterial composition of nanoparticles and their protein adsorption in the blood is of great significance in the design of drug-loaded nanoparticles. To explore the interaction between the different surface components of nanoparticles (NPs) and protein, we synthesized three kinds of pullulan NP polymers: cholesteric hydrophobically (CH) modified pullulan (CHP), CH-modified animated pullulan (CHAP), and CH-modified carboxylated pullulan (CHSP). Pullulan NPs were prepared by the dialysis method. Dynamic light scattering was used to determine the charge and size of the three NPs. The size of NPs was altered by the number of charge groups when polymers contain the same degree of cholesterol substitution. The zeta potentials were + 12.9, - 15.4, and - 0.698 mV for CHAP, CHSP, and CHP, respectively, and the dimensions were 116.9, 156.9, and 73.1 nm, respectively. Isothermal titration calorimetry was used to determine the thermodynamic changes of NPs with different surface charge, and the effect of human serum albumin (HSA) on the titration was investigated. The changes of enthalpy and entropy demonstrated an interaction between NPs and HSA; the binding constant (K) for CHSP, CHP, and CHAP was 1.41, 27.7, and 412 × 10 M, respectively, with the positive charge for CHAP-HSA, uncharged for CHP-HSA, and negative charge for CHSP-HSA complex. Fluorescence and circular dichroism spectroscopy were used to determine the protein structure change after the complexation between NPs and HSA. The NP and HSA complexation is a complicated process composed of protein α-helical content reduction and the peptide chain extension; CHP NPs had the largest reduction in HSA α-helical content. The drug release rates of all compounds of NP and HSA were significantly lower than those of free drug and drug-loaded NPs after 48 h. The highest and lowest rates were observed in CHSP-HSA and CHP-HSA, respectively. The drug release was significantly influenced by the adsorption of HSA on NPs, and the size and surface charge of NPs played an important role in this process.
纳米颗粒的纳米材料组成及其在血液中的蛋白质吸附情况在载药纳米颗粒的设计中具有重要意义。为了探究纳米颗粒(NPs)不同表面成分与蛋白质之间的相互作用,我们合成了三种支链淀粉NP聚合物:胆甾醇疏水(CH)修饰的支链淀粉(CHP)、CH修饰的胺化支链淀粉(CHAP)和CH修饰的羧化支链淀粉(CHSP)。通过透析法制备支链淀粉纳米颗粒。使用动态光散射来测定三种纳米颗粒的电荷和大小。当聚合物具有相同程度的胆固醇取代时,纳米颗粒的大小会因电荷基团的数量而改变。CHAP、CHSP和CHP的zeta电位分别为+12.9、-15.4和-0.698 mV,尺寸分别为116.9、156.9和73.1 nm。使用等温滴定量热法来测定具有不同表面电荷的纳米颗粒的热力学变化,并研究人血清白蛋白(HSA)对滴定的影响。焓和熵的变化表明纳米颗粒与HSA之间存在相互作用;CHSP、CHP和CHAP的结合常数(K)分别为1.41、27.7和412×10 M,CHAP-HSA复合物带正电荷,CHP-HSA复合物不带电荷,CHSP-HSA复合物带负电荷。使用荧光和圆二色光谱来测定纳米颗粒与HSA络合后蛋白质结构的变化。纳米颗粒与HSA的络合是一个由蛋白质α-螺旋含量降低和肽链延伸组成的复杂过程;CHP纳米颗粒使HSA的α-螺旋含量降低最多。48小时后,所有纳米颗粒与HSA化合物的药物释放率均显著低于游离药物和载药纳米颗粒。CHSP-HSA和CHP-HSA分别观察到最高和最低释放率。HSA在纳米颗粒上的吸附对药物释放有显著影响,纳米颗粒的大小和表面电荷在此过程中起重要作用。